News

As favor in the general market swings away from cell therapy, Immatics’ CEO is choosing to focus on what he can control: ...
This work shows how AI can help speed up and lower the cost of developing proteins used in medicine. For drug and biotech ...
(NYSE American: MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company focused on developing targeted ...
RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to ...
We are in an age where medicine is no longer one-size-fits-all; personalised healthcare is changing the diagnosis and ...
America’s lead here is narrower: it is ahead in chip design but East Asia remains the industrial centre of gravity. China, ...
The government says every corner of the country will benefit, but research backers call for a long-term plan for science.
“The multicellular nature of a plant – their roots, tissues, vegetative and reproductive organs- makes it a complex challenge ...
The great outdoors is often where engaged couples find their ideal wedding setting. Some especially have their hearts set on ...
The Gates Foundation has awarded Evaxion A/S (NASDAQ:EVAX) a grant to use its exclusive AI-Immunology™ technology to develop ...
The Radford University Board of Supervisors worked together to unanimously approve a proposal to create a new undergraduate ...
A new project, co-led by Dr Joshua James and Professor Patrick Cai of the Manchester Institute of Biotechnology at The ...